다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, v.25 no.1, 2015년, pp.34 - 40
Brandt, K. , Grunler, J. , Brismar, K. , Wang, J.
AI-Helper
Objective: A family of six insulin-like growth factor (IGF) binding-proteins (IGFBP) bind to IGF-I and IGF-II with high affinity and modulate their activity. We have recently shown that a neutrophil-derived protease activity cleaved IGFBP-1, -2 and -4. IGFBP-1 and IGFBP-2 have a C-terminal Arg-Gly-A...
Endocr. Rev. Jones 16 3 1995 Insulin-like growth factors and their binding proteins: biological actions
Endocr. Rev. Firth 23 824 2002 10.1210/er.2001-0033 Cellular actions of the insulin-like growth factor binding proteins
Trends Endocrinol. Metab.: TEM Bunn 14 176 2003 10.1016/S1043-2760(03)00049-3 Insulin-like growth factor binding protein proteolysis
Cell. Mol. Life Sci. Wang 63 2405 2006 10.1007/s00018-006-6248-7 Specific cleavage of insulin-like growth factor-binding protein-1 by a novel protease activity
Growth Hormon. IGF Res. Brandt 19 507 2009 10.1016/j.ghir.2009.05.002 IGFBP-1 protease activity and IGFBP-1 fragments in a patient with multiple myeloma
Growth Hormon. IGF Res. Brandt 21 167 2011 10.1016/j.ghir.2011.04.003 Neutrophil-derived azurocidin cleaves insulin-like growth factor-binding protein-1, -2 and -4
Proc. Natl. Acad. Sci. U. S. A. Jones 88 7481 1991 10.1073/pnas.88.17.7481 Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I
Mol. Hum. Reprod. Gibson 7 79 2001 10.1093/molehr/7.1.79 Regulation of IGF bioavailability in pregnancy
Biochem. Biophys. Res. Commun. Brewer 152 1289 1988 10.1016/S0006-291X(88)80425-X Cloning, characterization, and expression of a human insulin-like growth factor binding protein
Proc. Natl. Acad. Sci. U. S. A. Jones 90 10553 1993 10.1073/pnas.90.22.10553 Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence
J. Clin. Endocrinol. Metab. Gleeson 86 2484 2001 Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein Kinase pathway
Trends Endocrinol. Metab.: TEM Wheatcroft 20 153 2009 10.1016/j.tem.2009.01.002 IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis
Acta Paediatr. Scand. Suppl. Skottner 347 110 1988 Tissue repair and IGF-I
Oncogene Ammoun 31 1710 2012 10.1038/onc.2011.357 Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival
J. Mol. Endocrinol. Perks 22 141 1999 10.1677/jme.0.0220141 Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells
Mol. Biol. Cell Li 15 294 2004 10.1091/mbc.e03-05-0352 Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB
Horm. Res. Baxter 42 140 1994 10.1159/000184186 Insulin-like growth factor binding proteins in the human circulation: a review
Am. J. Physiol. Endocrinol. Metab. Baxter 278 E967 2000 10.1152/ajpendo.2000.278.6.E967 Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities
Mol. Cell. Endocrinol. Clemmons 140 19 1998 10.1016/S0303-7207(98)00024-0 Role of insulin-like growth factor binding proteins in controlling IGF actions
Proc. Natl. Acad. Sci. U. S. A. Elgin 84 3254 1987 10.1073/pnas.84.10.3254 An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I
Wound Repair Regen. Zhao 3 316 1995 10.1046/j.1524-475X.1995.30312.x Effects of insulin-like growth factor-I and insulin-like growth factor binding protein-1 on wound healing in a dermal ulcer model
Surgery Jyung 115 233 1994 Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1
Biochemistry Kuang 46 13720 2007 10.1021/bi701251d Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding
Invest. Ophthalmol. Vis. Sci. Pereira 45 4284 2004 10.1167/iovs.03-1052 Modulation of corneal epithelial cell functions by the neutrophil-derived inflammatory mediator CAP37
J. Biol. Chem. Sala 280 29812 2005 10.1074/jbc.M504304200 Structure and properties of the C-terminal domain of insulin-like growth factor-binding protein-1 isolated from human amniotic fluid
Am. J. Pathol. Lerman 162 303 2003 10.1016/S0002-9440(10)63821-7 Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia
J. Mol. Endocrinol. Schutt 32 859 2004 10.1677/jme.0.0320859 Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells
J. Biol. Chem. Wang 281 14085 2006 10.1074/jbc.M513686200 An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility
Biol. Reprod. Saso 86 1 2012 10.1095/biolreprod.111.094698 Role of Rho GTPases in human trophoblast migration induced by IGFBP1
Atherosclerosis Wang 220 102 2012 10.1016/j.atherosclerosis.2011.10.032 The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation
Thromb. Haemost. Soehnlein 102 198 2009 10.1160/TH08-11-0720 Neutrophils launch monocyte extravasation by release of granule proteins
Am. J. Physiol. Fan 269 R1204 1995 Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor
Am. J. Physiol. Fan 270 R621 1996 Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1
Proc. Soc. Exp. Biol. Med. Lee 216 319 1997 10.3181/00379727-216-44182 Insulin-like growth factor binding protein-1: recent findings and new directions
Lancet Boulton 366 1719 2005 10.1016/S0140-6736(05)67698-2 The global burden of diabetic foot disease
Am. J. Pathol. Goova 159 513 2001 10.1016/S0002-9440(10)61723-3 Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice
Folia Haematol. Wierusz-Wysocka 112 658 1985 Phagocytosis, bactericidal capacity, and superoxide anion (O2-) production by polymorphonuclear neutrophils from patients with diabetes mellitus
Am. J. Med. Rayfield 72 439 1982 10.1016/0002-9343(82)90511-3 Infection and diabetes: the case for glucose control
Eur. J. Biochem./FEBS Flodgaard 197 535 1991 10.1111/j.1432-1033.1991.tb15942.x Covalent structure of two novel neutrophile leucocyte-derived proteins of porcine and human origin. Neutrophile elastase homologues with strong monocyte and fibroblast chemotactic activities
J. Biol. Chem. Chertov 271 2935 1996 10.1074/jbc.271.6.2935 Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils
J. Exp. Med. Chertov 186 739 1997 10.1084/jem.186.5.739 Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils
Blood Soehnlein 112 1461 2008 10.1182/blood-2008-02-139634 Neutrophil secretion products pave the way for inflammatory monocytes
J. Clin. Invest. Soehnlein 118 3491 2008 10.1172/JCI35740 Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages
Protein Expr. Purif. Almeida 7 355 1996 10.1006/prep.1996.0053 Azurocidin, a natural antibiotic from human neutrophils: expression, antimicrobial activity, and secretion
Am. J. Pathol. Lee 160 841 2002 10.1016/S0002-9440(10)64907-3 CAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.